Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nattaro Labs | NATTA | Apr 25, 2024 | 0.73 | +5.04 |
Navigo Invest AB | NAVIGOSTAM | Apr 25, 2024 | 4.38 | -1.79 |
Navigo Invest Pref | NAVIGOPREF | Apr 25, 2024 | 107.00 | 0.00 |
NAXS | NAXS | Apr 25, 2024 | 64.80 | -0.31 |
NCAB Group | NCAB | Apr 25, 2024 | 66.70 | +1.21 |
NCC A | NCCA | Apr 25, 2024 | 128.00 | -4.48 |
NCC B | NCCB | Apr 25, 2024 | 128.00 | -4.83 |
Nederman Holding | NMAN | Apr 25, 2024 | 190.80 | +2.69 |
NEL | NELO | Apr 25, 2024 | 4.58 | -1.55 |
Nelly Group | NELLY | Apr 25, 2024 | 17.38 | +14.95 |
Neobo Fastigheter | NEOBO | Apr 25, 2024 | 15.81 | -1.16 |
NeoDynamics | NEOD | Apr 25, 2024 | 0.94 | +4.93 |
Neola Medical | NEOLA | Apr 25, 2024 | 1.89 | -1.56 |
Nepa | NEPA | Apr 25, 2024 | 27.10 | -1.45 |
Net Insight B | NETIB | Apr 25, 2024 | 4.94 | +1.33 |
Netel | NETEL | Apr 25, 2024 | 13.18 | -4.35 |
NetJobs Group | NJOB | Apr 25, 2024 | 0.32 | 0.00 |
New Nordic Healthbrands | NNH | Apr 25, 2024 | 20.20 | +1.51 |
New Wave B | NEWAB | Apr 25, 2024 | 95.40 | -11.58 |
Newbury Pharmaceuticals | NEWBRY | Apr 25, 2024 | 3.32 | -0.90 |
News55 | N55 | Apr 25, 2024 | 2.74 | -0.72 |
Nexam Chemical Holding | NEXAM | Apr 25, 2024 | 3.14 | +0.64 |
Nexar Group | NXAR | Apr 25, 2024 | 0.21 | -18.32 |
NextCell Pharma AB | NXTCL | Apr 25, 2024 | 1.30 | -45.63 |
NFO Drives | NFO | Apr 25, 2024 | 31.60 | -2.47 |
Ngenic | NGENIC | Apr 25, 2024 | 7.30 | -0.82 |
NGS Group | NGS | Apr 25, 2024 | 3.14 | -1.88 |
Nibe Industrier B | NIBEB | Apr 25, 2024 | 50.16 | -1.18 |
Nicoccino Holding | NICO | Apr 25, 2024 | 1.14 | 0.00 |
Nilsson Special Vehicles | NILS | Apr 25, 2024 | 8.90 | +1.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.